Retraction
Id1 Deficiency Protects Against Tumor Formation in ApcMin/+ Mice but not in a Mouse Model of Colitis-associated Colon Cancer
Paper Information
Record ID:
37444
Author(s):
Publication Date:
April 01, 2015
Retraction Date:
June 02, 2022
(3.5 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Medicine, Weill Cornell Medical College, New York, New York
- Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York
- Department of Pathology and Laboratory Medicine,Weill Cornell Medical College, New York, New York
- Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, New York
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1158/1940-6207.CAPR-22-0208Citations (11)
11
Total Citations2
Post-Retraction(18.2%)
8
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
0
Within 1 year
1
After 2+ years
772
Days since retraction (latest)
Assessment of ID family proteins expression in colorectal cancer of Iraqi patients
Saja Ali Abbas, Israa Hussein Hamzah
Molecular Biology Reports
Published: Jul 2024
772 days after retraction
<i>Id1, Spp1</i>and<i>Pak3</i>are biomarkers of<i>Smad4</i>and TGF-β1 dependency in conditional intestinal adenoma, organoids and colorectal cancer
Mirvat Surakhy, Julia Matheson, David Barnes et al. (11 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Mar 2024
656 days after retraction
Retraction: Id1 Deficiency Protects Against Tumor Formation in ApcMin/+ Mice but not in a Mouse Model of Colitis-associated Colon Cancer
Ning Zhang, Kotha Subbaramaiah, Rhonda K. Yantiss et al. (7 authors)
Cancer Prevention Research
Open Access
Published: Jun 2022
Same day as retraction
Anti-tumor effects of an ID antagonist with no observed acquired resistance
Paulina M. Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang et al. (27 authors)
npj Breast Cancer
Open Access
Published: May 2021
17 citations
17 citations
374 days before retraction
Anti-tumor effects of an Id antagonist with no acquired resistance
Paulina M. Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang et al. (23 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: Jan 2020
3 citations
3 citations
878 days before retraction
Inhibitor of Differentiation 1 (Id1) in Cancer and Cancer Therapy
Zhengxiao Zhao, Zhiyuan Bo, Weiyi Gong et al. (4 authors)
International Journal of Medical Sciences
Open Access
Published: Jan 2020
83 citations
83 citations
883 days before retraction
The application of ApcMin/+ mouse model in colorectal tumor researches
J. Ren, Hua Sui, Fanfu Fang et al. (5 authors)
Journal of Cancer Research and Clinical Oncology
Published: Mar 2019
55 citations
55 citations
1172 days before retraction
Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis.
Jing Ke, Ruolin Wu, Yong Chen et al. (4 authors)
PubMed
Published: Jan 2018
32 citations
32 citations
1613 days before retraction
Id Proteins Contribute to Tumor Development and Metastatic Colonization in a Model of Bladder Carcinogenesis
Marta Garcı́a-Cao, Hikmat Al‐Ahmadie, Yvette Chin et al. (5 authors)
Bladder Cancer
Open Access
Published: Oct 2015
2 citations
2 citations
2411 days before retraction
Id1 Expression in Endothelial Cells of the Colon Is Required for Normal Response to Injury
Ning Zhang, Kotha Subbaramaiah, Rhonda K. Yantiss et al. (9 authors)
American Journal Of Pathology
Open Access
Published: Sep 2015
10 citations
10 citations
2462 days before retraction
Id2 deletion attenuates <i>Apc</i>-deficient ileal tumor formation
Kyoko Biyajima, Fumihiko Kakizaki, Xiaodong Shen et al. (7 authors)
Biology Open
Open Access
Published: Jun 2015
4 citations
4 citations
2536 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
3.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025